A study to assess the effect of pneumococcal vaccination on the indicators of Systemic Inflammation and the State of Carbohydrate Metabolism in Patients with COPD and Type 2 Diabetes
Latest Information Update: 03 Jul 2020
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
Most Recent Events
- 03 Jul 2020 New trial record
- 20 May 2020 Results presented at the 116th International Conference of the American Thoracic Society